You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 3, March 1975 TABLE OF CONTENTS
  Archives
  •  Online Features
  CARDIAC ELECTROPHYSIOLOGY SYMPOSIUM
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ventricular Fibrillation Threshold

Its Physiological and Pharmacological Importance

E. Neil Moore, DVM, PhD; Joseph F. Spear, PhD

Arch Intern Med. 1975;135(3):446-453.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Ventricular fibrillation is one of the primary causes of early sudden death after myocardial infarction.1 Ventricular fibrillation is usually initiated by either a rapid ventricular tachyarrhythmia or a premature ventricular contraction falling within the vulnerable phase of the preceding beat (R-on-T phenomenon).2 The initiation and maintenance of the tachyarrhythmia or premature ventricular contraction can be due to either a reentrant mechanism or abnormal ectopic activity.3 If a patient with myocardial infarction survives until admittance into a modern coronary care unit and is not in cardiogenic shock, the dysrhythmias and ventricular fibrillation can usually be controlled by electrical and pharmacological means.

The present report deals primarily with recent studies using the experimental technique of measuring the ventricular fibrillation threshold by applying electrical current to the heart. Particular emphasis is placed on some of the recent findings regarding the electrophysiology and electropharmacology of initiation and prevention of ventricular fibrillation. . . . [Full Text PDF of this Article]


Author Affiliations

From the Comparative Cardiovascular Studies Unit, School of Veterinary Medicine and Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia.


Footnotes

Received for publication Nov 6, 1974; accepted Nov 12.

Reprint requests to 3800 Spruce St H1, Philadelphia, PA 19174 (Dr. Moore).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.